Nuwellis (NUWE) vs Profusa (PFSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nuwellis is the larger company by market cap ($2.5 million vs $902,414), about 2.7 times the size. On valuation, Nuwellis trades at a lower trailing P/E (0.0x vs 0.0x for Profusa).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUWE | PFSA |
|---|---|---|
| Share price | $0.68 | $1.49 |
| Market cap | $2.48M | $902.41K |
| 1-day change | +0.73% | 0.00% |
| P/E ratio (TTM) | 0.00 | 0.00 |
| EPS (TTM) | $435.92 | $897.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $172.90 | $3,000.00 |
| 52-week low | $0.67 | $1.40 |
| Distance from 52-week high | -99.61% | -99.95% |
| Average volume | 4.33M | 2.74M |
| Shares outstanding | 3.65M | 605.65K |
| Employees | 38 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nuwellis is about 2.7 times larger than Profusa by market value ($2.48M vs $902.41K).
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees
About Profusa
PFSA stock →Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
Health Care · Medical/Dental Instruments
NUWE vs PFSA FAQ
Which is bigger, Nuwellis or Profusa?
Nuwellis (NUWE) is larger, with a market capitalization of $2.48M compared with $902.41K for Profusa (PFSA).
Which has the lower P/E ratio, NUWE or PFSA?
NUWE has the lower trailing P/E at 0.0, versus 0.0 for PFSA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Nuwellis and Profusa in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Nuwellis and Medical/Dental Instruments for Profusa.